Matches in Wikidata for { <http://www.wikidata.org/entity/Q89833310> ?p ?o ?g. }
- Q89833310 description "2019 nî lūn-bûn" @default.
- Q89833310 description "2019年の論文" @default.
- Q89833310 description "2019年学术文章" @default.
- Q89833310 description "2019年学术文章" @default.
- Q89833310 description "2019年学术文章" @default.
- Q89833310 description "2019年学术文章" @default.
- Q89833310 description "2019年学术文章" @default.
- Q89833310 description "2019年学术文章" @default.
- Q89833310 description "2019年學術文章" @default.
- Q89833310 description "2019年學術文章" @default.
- Q89833310 description "2019年學術文章" @default.
- Q89833310 description "2019年學術文章" @default.
- Q89833310 description "2019年學術文章" @default.
- Q89833310 description "2019년 논문" @default.
- Q89833310 description "article científic" @default.
- Q89833310 description "article scientific" @default.
- Q89833310 description "article scientifique" @default.
- Q89833310 description "articol științific" @default.
- Q89833310 description "articolo scientifico" @default.
- Q89833310 description "artigo científico" @default.
- Q89833310 description "artigo científico" @default.
- Q89833310 description "artigo científico" @default.
- Q89833310 description "artikel ilmiah" @default.
- Q89833310 description "artikull shkencor" @default.
- Q89833310 description "artikulong pang-agham" @default.
- Q89833310 description "artykuł naukowy" @default.
- Q89833310 description "artículo científico publicado en 2019" @default.
- Q89833310 description "artículu científicu" @default.
- Q89833310 description "bilimsel makale" @default.
- Q89833310 description "bài báo khoa học" @default.
- Q89833310 description "naučni članak" @default.
- Q89833310 description "scienca artikolo" @default.
- Q89833310 description "scientific article published in July 2019" @default.
- Q89833310 description "scientific article published in July 2019" @default.
- Q89833310 description "scientific article published on 01 July 2019" @default.
- Q89833310 description "teaduslik artikkel" @default.
- Q89833310 description "tieteellinen artikkeli" @default.
- Q89833310 description "tudományos cikk" @default.
- Q89833310 description "vedecký článok" @default.
- Q89833310 description "vetenskaplig artikel" @default.
- Q89833310 description "videnskabelig artikel udgivet juli 2019" @default.
- Q89833310 description "vitenskapelig artikkel" @default.
- Q89833310 description "vitskapeleg artikkel" @default.
- Q89833310 description "vědecký článek" @default.
- Q89833310 description "wetenschappelijk artikel" @default.
- Q89833310 description "wissenschaftlicher Artikel" @default.
- Q89833310 description "επιστημονικό άρθρο" @default.
- Q89833310 description "мақолаи илмӣ" @default.
- Q89833310 description "наукова стаття, опублікована в липні 2019" @default.
- Q89833310 description "научна статия" @default.
- Q89833310 description "научная статья" @default.
- Q89833310 description "научни чланак" @default.
- Q89833310 description "научни чланак" @default.
- Q89833310 description "מאמר מדעי" @default.
- Q89833310 description "مقالة علمية نشرت في يوليو 2019" @default.
- Q89833310 description "জুলাই ২০১৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q89833310 description "บทความทางวิทยาศาสตร์" @default.
- Q89833310 description "სამეცნიერო სტატია" @default.
- Q89833310 name "FOLFIRI plus panitumumab as second-line treatment in mutated RAS metastatic colorectal cancer patients who converted to wild type RAS after receiving first-line FOLFOX/CAPOX plus bevacizumab-based treatment: Phase II CONVERTIX trial" @default.
- Q89833310 name "FOLFIRI plus panitumumab as second-line treatment in mutated RAS metastatic colorectal cancer patients who converted to wild type RAS after receiving first-line FOLFOX/CAPOX plus bevacizumab-based treatment: Phase II CONVERTIX trial" @default.
- Q89833310 type Item @default.
- Q89833310 label "FOLFIRI plus panitumumab as second-line treatment in mutated RAS metastatic colorectal cancer patients who converted to wild type RAS after receiving first-line FOLFOX/CAPOX plus bevacizumab-based treatment: Phase II CONVERTIX trial" @default.
- Q89833310 label "FOLFIRI plus panitumumab as second-line treatment in mutated RAS metastatic colorectal cancer patients who converted to wild type RAS after receiving first-line FOLFOX/CAPOX plus bevacizumab-based treatment: Phase II CONVERTIX trial" @default.
- Q89833310 prefLabel "FOLFIRI plus panitumumab as second-line treatment in mutated RAS metastatic colorectal cancer patients who converted to wild type RAS after receiving first-line FOLFOX/CAPOX plus bevacizumab-based treatment: Phase II CONVERTIX trial" @default.
- Q89833310 prefLabel "FOLFIRI plus panitumumab as second-line treatment in mutated RAS metastatic colorectal cancer patients who converted to wild type RAS after receiving first-line FOLFOX/CAPOX plus bevacizumab-based treatment: Phase II CONVERTIX trial" @default.
- Q89833310 P1433 Q89833310-436A9E53-ADC4-4876-8AA9-263F753CA662 @default.
- Q89833310 P1476 Q89833310-3E971B17-8E6A-4A90-8CFF-00415537623B @default.
- Q89833310 P2093 Q89833310-00D211CA-4C2F-411C-B23E-D87A68673D7C @default.
- Q89833310 P2093 Q89833310-4561B2E2-4AE4-42DD-BBF9-DB62F268D47F @default.
- Q89833310 P2093 Q89833310-524FC1C6-4258-4F7C-8452-96EE2FA0213F @default.
- Q89833310 P2093 Q89833310-5A8E9358-8977-4538-AF85-98D635BE566C @default.
- Q89833310 P2093 Q89833310-A7F5E1BD-E8DB-4C7B-A9B0-66FE2CAE987F @default.
- Q89833310 P2093 Q89833310-D4A36B28-9664-4977-B0A1-351DE9F97153 @default.
- Q89833310 P2093 Q89833310-E121D799-6B0E-4F28-BCFC-ED914661B562 @default.
- Q89833310 P304 Q89833310-B8A305BE-C593-4927-9BB6-7C8BDFA79180 @default.
- Q89833310 P31 Q89833310-674FCBC3-0792-4668-B140-5E75B73A4C9C @default.
- Q89833310 P356 Q89833310-90C794F6-C50F-4A72-9847-441E40D3AF99 @default.
- Q89833310 P478 Q89833310-80AD23C6-37B9-4582-9195-1D8132552278 @default.
- Q89833310 P577 Q89833310-C9444895-9E49-4BC2-B58D-6296F9BFEB11 @default.
- Q89833310 P921 Q89833310-1D02A591-D1F3-422A-8E19-7CA4C79086B3 @default.
- Q89833310 P921 Q89833310-5FEB184D-34D8-4CC9-B093-3A392DA99970 @default.
- Q89833310 P921 Q89833310-C36013C6-3C2E-45CB-A73C-911B71169810 @default.
- Q89833310 P921 Q89833310-C8A89296-5B13-49F0-BAE4-D1199E705DF1 @default.
- Q89833310 P356 MDZ155.088 @default.
- Q89833310 P1433 Q326122 @default.
- Q89833310 P1476 "FOLFIRI plus panitumumab as second-line treatment in mutated RAS metastatic colorectal cancer patients who converted to wild type RAS after receiving first-line FOLFOX/CAPOX plus bevacizumab-based treatment: Phase II CONVERTIX trial" @default.
- Q89833310 P2093 "A Cousillas Castiñeiras" @default.
- Q89833310 P2093 "A Fernández Montes" @default.
- Q89833310 P2093 "J De la Cámara Gómez" @default.
- Q89833310 P2093 "J Méndez Méndez" @default.
- Q89833310 P2093 "M Covela Rúa" @default.
- Q89833310 P2093 "N Martinez Lago" @default.
- Q89833310 P2093 "P Gonzalez Villarroel" @default.
- Q89833310 P304 "iv23-iv24" @default.
- Q89833310 P31 Q13442814 @default.
- Q89833310 P356 "10.1093/ANNONC/MDZ155.088" @default.
- Q89833310 P478 "30 Suppl 4" @default.
- Q89833310 P577 "2019-07-01T00:00:00Z" @default.
- Q89833310 P921 Q108566365 @default.
- Q89833310 P921 Q188874 @default.